Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China

doi:10.12998/wjcc.v10.i2.426

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3305)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-10) series.

Item

Count

PDF

228

WORD

113

HTML

1702

Tables (1-10)

206

Sum=2249

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

281

Download

775

Sum=1056

Jan 14, 2022 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Jan 14, 2022; 10(2): 426-436
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.426

Table 7 Comparison of laboratory results between the two groups before and after the medication (median)

Indicator	group	Before medication	After medication
hs-CRP	Control group	2.38 (1.12-10.96)	1.57 (1.33-3.20)
hs-CRP	Corticosteroid group	5.65 (1.57-22.0)	2.75 (0.87-9.0)
IL-6	Control group	8.29 (6.81-11.14)	6.60 (5.64-8.38)
IL-6	Corticosteroid group	10.30 (7.78-13.08)	8.21 (6.26-9.79)
CK-MB	Control group	0.60 (0.40-1.15)	0.60 (0.40-0.90)
CK-MB	Corticosteroid group	6.0 (0.90-8.80)	4.25 (0.80-6.90)
D-dimer	Control group	0.80 (0.40-1.05)	0.54 (0.20-0.80)
D-dimer	Corticosteroid group	1.14 (0.85-1.89)	0.89 (0.57-1.08)

hs-CRP: Hypersensitive C-reactive protein; IL-6: Interleukin-6; CK-MB: Creatine kinase-MB.

Citation: Lin L, Xue D, Chen JH, Wei QY, Huang ZH. Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China. World J Clin Cases 2022; 10(2): 426-436
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/426.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.426